Skip to content
Screener

LivaNova LIVN Neuromodulation — Total Assets

Other segment segments

Cardiopulmonary
$1.05B+3.7%

Similar metrics at other companies

VAN
VANINeuromodulation Division — Total Assets
$500K-28.6%
Apollo Global Management logo
APOAsset Management — Total Assets
$20.46B+42.0%
Asset Entities logo
ASSTAsset Management — Total Assets
$1.28M
Equitable Holdings logo
EQHAsset Management — Total Assets
$10.34B-3.4%
Rithm Capital logo
RITMAsset management — Total Assets
$4.5B+84.6%
KKR & Co. logo
KKRAsset Management — Total Assets
$28.02B-0.3%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemJune 30, 2026December 31, 2025
Cardiopulmonary$1,051,493$1,045,189
Neuromodulation651,784639,742
Other assets (1)937,584921,122
$2,640,861$2,606,053

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's neuromodulation — total assets?
LivaNova (LIVN) reported neuromodulation — total assets of $651.78M in Q2 2026.
How has LivaNova's neuromodulation — total assets changed year-over-year?
LivaNova's neuromodulation — total assets increased by 2.2% year-over-year, from $637.72M to $651.78M.
What is the long-term trend for LivaNova's neuromodulation — total assets?
Over 4 years (2021 to 2025), LivaNova's neuromodulation — total assets has grown at a -0.4% compound annual growth rate (CAGR), from $2.6B to $2.56B.
What does neuromodulation — total assets mean?
The total value of resources controlled by the Neuromodulation segment, including inventory, property, plant, equipment, and intangible assets. This metric provides insight into the capital intensity and asset base supporting the segment's operations.

Ask your AI about LivaNova's neuromodulation — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude